How Prizume works
Prizume answers one question: is a company's share price above or below what the business is worth? It never tells you to buy or sell. It shows its working so you can judge for yourself.
1. The evidence: the company's own filings
Every US-listed company files an annual report (the 10-K) with the Securities and Exchange Commission. We download it and read the numbers that matter: sales, profit, cash, debt, investment and the number of shares. Prices come from the market on the day we value it.
2. Eight ways to value it
No single method is right. Some add up the cash the business will bring in, some look at what similar companies trade at, some look only at dividends or at the books. We run eight, show every result, and blend them into a range, because pretending to know the value to the cent would be dishonest.
3. Compare with the price
If the price is below the range, the market expects less than the business has been delivering. If it is above, the price already assumes strong growth. The company pages show exactly how much growth the price assumes, and let you drag the assumptions yourself.
4. Forecasts that can't be faked
Anyone can claim they predicted a result after it happens. Here, a forecast is locked before the company reports: only a digital fingerprint is published, with the time. After the results, the forecast is revealed; anyone can check it matches the fingerprint, and it is scored against what the company actually reported. The proof log is public, chained so nothing can be edited, and stamped on the Bitcoin blockchain so not even we could rewrite it.
5. We test ourselves too
We checked our own cheap-or-expensive verdict against history: it did not reliably predict which shares would beat the market. We publish that, because the point is not to pick winners. It is to understand what a price assumes.